Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma.

Elena V Poddubskaya,Madina P Baranova,Daria O Allina,Philipp Y Smirnov,Eugene A Albert,Alexey P Kirilchev,Alexey A Aleshin,Marina I Sekacheva,Maria V Suntsova

Experimental hematology & oncology（2018）

引用 34|浏览1

暂无评分

摘要

This case evidences that sequential personalized prescription of different TKIs may show promising efficacy in terms of survival and quality of life in MCC.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要